Wetherby Asset Management Inc Regeneron Pharmaceuticals, Inc. Transaction History

Wetherby Asset Management Inc

  • $2.04 Billion
  • Q4 2024

A detailed history of Wetherby Asset Management Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Wetherby Asset Management Inc holds 2,326 shares of REGN stock, worth $1.29 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
2,326
Previous 2,490 6.59%
Holding current value
$1.29 Million
Previous $2.62 Million 36.72%
% of portfolio
0.08%
Previous 0.12%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
$701.85 - $1046.91 $115,103 - $171,693
-164 Reduced 6.59%
2,326 $1.66 Million
Q3 2024

Nov 14, 2024
SELL
$1024.09 - $1201.76 $31,746 - $37,254
-31 Reduced 1.23%
2,490 $2.62 Million
Q2 2024

Aug 14, 2024
SELL
$883.2 - $1071.19 $37,977 - $46,061
-43 Reduced 1.68%
2,521 $2.65 Million
Q1 2024

May 15, 2024
SELL
$902.69 - $993.35 $30,691 - $33,773
-34 Reduced 1.31%
2,564 $2.47 Million
Q4 2023

Feb 14, 2024
SELL
$775.18 - $881.7 $8,526 - $9,698
-11 Reduced 0.42%
2,598 $2.28 Million
Q3 2023

Nov 14, 2023
SELL
$692.45 - $844.37 $24,235 - $29,552
-35 Reduced 1.32%
2,609 $2.15 Million
Q2 2023

Aug 14, 2023
SELL
$700.03 - $830.35 $76,303 - $90,508
-109 Reduced 3.96%
2,644 $1.9 Million
Q1 2023

May 12, 2023
BUY
$680.49 - $826.97 $85,741 - $104,198
126 Added 4.8%
2,753 $2.26 Million
Q4 2022

Feb 14, 2023
BUY
$705.89 - $766.39 $95,295 - $103,462
135 Added 5.42%
2,627 $1.9 Million
Q3 2022

Nov 14, 2022
BUY
$573.97 - $724.32 $137,752 - $173,836
240 Added 10.66%
2,492 $1.72 Million
Q2 2022

Aug 15, 2022
SELL
$548.35 - $738.84 $91,026 - $122,647
-166 Reduced 6.87%
2,252 $1.33 Million
Q1 2022

May 16, 2022
BUY
$595.12 - $698.43 $64,272 - $75,430
108 Added 4.68%
2,418 $1.69 Million
Q4 2021

Feb 14, 2022
BUY
$543.48 - $670.97 $25,543 - $31,535
47 Added 2.08%
2,310 $1.46 Million
Q3 2021

Nov 15, 2021
BUY
$574.03 - $680.96 $22,961 - $27,238
40 Added 1.8%
2,263 $1.37 Million
Q2 2021

Aug 16, 2021
BUY
$472.8 - $558.54 $120,091 - $141,869
254 Added 12.9%
2,223 $1.24 Million
Q1 2021

May 14, 2021
SELL
$446.73 - $548.2 $109,448 - $134,309
-245 Reduced 11.07%
1,969 $931,000
Q4 2020

Feb 11, 2021
BUY
$478.3 - $607.98 $58,830 - $74,781
123 Added 5.88%
2,214 $1.07 Million
Q3 2020

Dec 16, 2020
SELL
$544.75 - $658.21 $126,382 - $152,704
-232 Reduced 9.99%
2,091 $1.17 Million
Q3 2020

Nov 13, 2020
BUY
$544.75 - $658.21 $160,156 - $193,513
294 Added 14.49%
2,323 $1.3 Million
Q2 2020

Aug 14, 2020
BUY
$493.32 - $643.92 $97,184 - $126,852
197 Added 10.75%
2,029 $1.27 Million
Q1 2020

May 06, 2020
BUY
$336.18 - $494.43 $106,905 - $157,228
318 Added 21.0%
1,832 $895,000
Q4 2019

Jan 28, 2020
BUY
$274.13 - $376.51 $148,304 - $203,691
541 Added 55.6%
1,514 $569,000
Q3 2019

Oct 31, 2019
SELL
$273.46 - $318.39 $29,807 - $34,704
-109 Reduced 10.07%
973 $270,000
Q2 2019

Jul 25, 2019
SELL
$299.6 - $414.82 $144,107 - $199,528
-481 Reduced 30.77%
1,082 $338,000
Q1 2019

May 09, 2019
SELL
$372.08 - $439.57 $5,581 - $6,593
-15 Reduced 0.95%
1,563 $642,000
Q4 2018

Jan 30, 2019
BUY
$335.82 - $403.04 $78,917 - $94,714
235 Added 17.5%
1,578 $589,000
Q3 2018

Nov 07, 2018
BUY
$351.14 - $408.51 $155,906 - $181,378
444 Added 49.39%
1,343 $543,000
Q2 2018

Jul 24, 2018
SELL
$284.6 - $344.99 $32,444 - $39,328
-114 Reduced 11.25%
899 $310,000
Q1 2018

May 04, 2018
SELL
$315.82 - $393.78 $213,494 - $266,195
-676 Reduced 40.02%
1,013 $349,000
Q4 2017

Feb 09, 2018
BUY
$358.63 - $469.95 $35,504 - $46,525
99 Added 6.23%
1,689 $635,000
Q3 2017

Nov 13, 2017
BUY
$431.38 - $504.0 $685,894 - $801,360
1,590
1,590 $711,000

Others Institutions Holding REGN

# of Institutions
1,431
Shares Held
84.9M
Call Options Held
1.39M
Put Options Held
1.42M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $59.5B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Wetherby Asset Management Inc Portfolio

Follow Wetherby Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wetherby Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wetherby Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email